Given the expanding indications of transcatheter aortic valve replacement (TAVR) in
younger patients with longer life expectancies, the ability to perform postprocedural coronary …

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation
(TAVI) has revolutionized the management of aortic stenosis (AS). Through striking …

Within the last two decades, transcatheter aortic valve replacement (TAVR) has
revolutionized the management of symptomatic severe aortic stenosis (AS). Newer …

Transcatheter aortic valve implantation (TAVI) within failed bioprosthetic surgical aortic
valves (valve-invalve TAVI) has become an established procedure, currently approved for …

Background: Left ventricular outflow tract obstruction complicates hypertrophic
cardiomyopathy and transcatheter mitral valve replacement. Septal reduction therapies …

Abstract Background and Aims This trial sought to assess the safety and efficacy of ShortCut,
the first dedicated leaflet modification device, prior to transcatheter aortic valve implantation …

It has been more than 20 years since the first in man transcatheter aortic valve intervention
(TAVI), and during this period we have witnessed an impressive evolution of this technique …

Background Transcatheter aortic valve replacement (TAVR)–related coronary artery
obstruction prediction remains unsatisfactory despite high mortality and novel preventive …

Objectives The aims of this study were to determine the rate of noncentered coronary ostia
and their risk for coronary overlap (CO) and to develop an improved orientation strategy for …

Background Coronary obstruction (CO) is a potentially life-threatening complication of
transcatheter aortic valve replacement (TAVR). Chimney stenting or leaflet laceration with …